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Bone is a hierarchical hard tissue that consists of oriented 
crystals of hydroxyapatite (HAP, Ca10(PO4)6(OH)2) embedded 
within type I collagen fibrils.[1,2] The 2–4 nm thick HAP crys-
talline platelets in bone significantly enhance the stiffness 
and toughness of the collagen fibrils by dissipating the ten-
sion loaded on the structure.[3–5] Undernutrition and pro-
tein deficiency can cause a reduced bone mineral density, 
which increases the risk of osteoporosis.[6,7] Osteoporosis is a 
Osteoporosis is an incurable chronic disease characterized by a lack of mineral 
mass in the bones. Here, the full recovery of osteoporotic bone is achieved by 
using a calcium phosphate polymer-induced liquid-precursor (CaP-PILP). This 
free-flowing CaP-PILP material displays excellent bone inductivity and is able 
to readily penetrate into collagen fibrils and form intrafibrillar hydroxyapatite 
crystals oriented along the c-axis. This ability is attributed to the microstruc-
ture of the material, which consists of homogeneously distributed ultrasmall 
(≈1 nm) amorphous calcium phosphate clusters. In vitro study shows the 
strong affinity of CaP-PILP to osteoporotic bone, which can be uniformly 
distributed throughout the bone tissue to significantly increase the bone 
density. In vivo experiments show that the repaired bones exhibit satisfactory 
mechanical performance comparable with normal ones, following a prom-
ising treatment of osteoporosis by using CaP-PILP. The discovery provides 
insight into the structure and property of biological nanocluster materials and 
their potential for hard tissue repair.
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worldwide bone disease, characterized by 
a lack of HAP in bone and an associated 
increased risk of fracture.[8,9] The cur-
rent clinical treatments of osteoporosis 
largely rely on drugs, including vitamin 
D,[10,11] bisphosphonate,[12,13] and calcium 
supplements.[14] However, as these treat-
ments cannot return osteoporotic bone 
to its healthy state, osteoporosis is now 
generally accepted as an incurable chronic 
disease.[15] Up to now, autogenous bone 
grafts have been considered the “gold 
standard” for bone replacement, but have 
limited availability and potential compat-
ibility issues.[16,17] Hence, many bone-
substitute materials such as bone cement, 
mesoporous scaffolds, synthetic compos-
ites, and hydrogels have been explored for 
bone regeneration.[18–22] However, these 
repair materials are not able to regen-
erate osteoporotic bone by remineral-
izing bone collagen fibrils. Here, we propose that osteoporotic 
bone can be recovered by remineralizing the collagen fibrils in 
the affected bone. Although a number of calcium phosphate 
(CaP)-based biomedical nanomaterials have been developed 
and successfully used for repairing bone defects,[23–25] remin-
eralizing the collagen fibrils in bone in vivo remains a great 
challenge. This limitation can be understood by taking a close 
look at the collagen fibril structure. The collagen fibril is an 
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assembly of quasi-hexagonally packed, twisted collagen triple-
helix molecules[26] that contain only ≈1.8–4 nm sized tortuous 
subchannels.[27] Such a structure is inaccessible to most CaP 
nanomaterials and thereby makes the recovery of the affected 
bone difficult.
The polymer-induced liquid-precursor (PILP) was first 
reported for calcium carbonate[28] and was then extended to 
calcium phosphate.[29–31] PILP is a liquid-like mineral pre-
cursor stabilized by charged polymers, such as polyacrylic acid 
(PAA),[31] poly(allylamine hydrochloride) (PAH),[32] or polyas-
partic acid (PASP),[28] that forms thin films on flat substrates 
and can infiltrate into nanopores.[28,33,34] In vitro experiments 
have shown that the calcium phosphate PILP is able to infil-
trate into collagen fibrils and form oriented intrafibrillar HAP 
crystallites, with a diffraction pattern indistinguishable from 
that of the mineralized collagen fibrils in bone.[31,35] Despite the 
unique liquid-like properties of PILP and its possible vital role 
in the biomineralization processes,[36] its microstructure is still 
under debate. While early studies suggest that PILP appears as 
a dense liquid phase,[28,37] cryo-transmission electron micros-
copy (cryoTEM) observations showed only amorphous calcium 
phosphate (ACP) nanoclusters in the early stage of in vitro 
collagen remineralization experiments, where the calcium 
phosphate PILP is supposed to form.[33,35] Similarly, a recent 
cryoTEM study using a calcium carbonate system indicated that 
PILP is actually a polymer-driven assembly of nanoclusters.[34] 
Although calcium phosphate PILP displays a promising ability 
to remineralize collagen fibrils, it has not yet been applied 
in biomedical bone engineering. A major challenge is that 
the calcium phosphate PILP is generally synthesized at low 
Ca2+/PO43− concentrations,[31] which are insufficient to provide 
the mineral mass required for the recovery of demineralized 
bone at the macroscopic scale.
In the present work, we demonstrate that the full recovery of 
osteoporotic bone can be achieved using a free-flowing calcium 
phosphate polymer-induced liquid-precursor (CaP-PILP) mate-
rial. By combining two biocompatible polymeric additives, PAA 
and PASP, CaP-PILP is stabilized on a large scale and at a high 
Ca2+/PO43− concentration. In contrast to previous CaP mate-
rials for bone repair, this CaP-PILP material has excellent bone 
inductivity, which uniquely allows the intrafibrillar mineraliza-
tion of collagen fibrils. This is directly related to its microstruc-
ture, which contains a high density of uniform-sized (≈1 nm) 
ACP nanoclusters. Both in vitro and in vivo experiments pro-
vide the first proof that the structural and mechanical proper-
ties of osteoporotic bone can be recovered to those of healthy 
bone by treatment with CaP-PILP.
Two biocompatible, negatively charged polymers, PAA 
and PASP, were used in the synthesis of our CaP-PILP mate-
rial. PAA with sufficient molecular weight is able to stabilize 
the PILP phase of CaP.[38] However, this polymer also causes 
precipitates to form when mixed with high concentrations of 
Ca2+. To generate a stable CaP-PILP at a high Ca2+ without pre-
cipitation, we used PASP to bind Ca2+ as a competitor to PAA. 
In a typical procedure, 2.0 mL of a 0.1 m CaCl2 solution was 
mixed with 0.2 mL of a 0.3 g mL−1 PASP solution to obtain 
solution A, while 2.0 mL of a 0.1 m Na2HPO4 solution was 
mixed with 0.4 mL of a solution containing 0.3 g mL−1 PAA 
to obtain solution B. Then, 2.4 mL of solution B was slowly 
injected into 2.2 mL of solution A with vigorous stirring. The 
negatively charged carboxylate groups on PAA/PASP chains 
can bind with Ca2+ and prevent it from precipitating immedi-
ately with HPO42−, so that the PILP phase can be formed. The 
PILP phase forms with relatively low concentration of charged 
polymers (<20 mg L−1) and Ca2+ (≤5 × 10−3 m).[31,35] However, 
in this work we aim to form a high concentration of CaP-PILP 
so that it can sufficiently support the repair of osteoporotic 
bones, therefore a high concentration of PAA/PASP (26.1 and 
13.0 mg mL−1) was used, with the maximal amount of Ca2+ 
that can be chelated by the PAA/PASP, which is 43.5 × 10−3 m. 
The resulting material is transparent and viscous but still free 
flowing (Figure 1a; Movie S1, Supporting Information). Cryo-
genic electron tomography (cryoET) showed that the resulting 
material is densely loaded with uniform-sized, separate, and 
homogeneously distributed nanoclusters, indicating the 
formation of CaP-PILP (Figure 1b; Movie S2, Supporting 
Information). In the PILP process, PAA and PASP are used to 
stabilize and form an amorphous precursor that is sufficiently 
hydrated to be a liquid phase. The close-to-focus cryoTEM 
images (defocus = −1 µm) showed that the clusters are ≈1 nm 
in size (inset 1 of Figure 1b).[5,39] Selected area electron diffrac-
tion (SAED, inset 2 of Figure 1b) showed a broad diffraction 
band, while powder X-ray diffraction (pXRD) showed a broad 
peak at ≈2θ = 30° (Figure S1a, Supporting Information); both 
results indicate that the clusters are ACP. This assignment 
was further confirmed by Fourier transform infrared (FT-IR) 
spectroscopy, which revealed two wide bands typical of phos-
phate stretching (v3) at 1055 cm−1 and phosphate bending 
(v4) at 560 cm−1 (Figure S1b, Supporting Information). The 
dynamic mechanical properties of CaP-PILP were examined by 
frequency-dependent oscillatory shear rheology (Figure 1c). The 
measurements revealed a dynamic storage modulus (G′) that 
was slightly lower than the loss modulus (G″), confirming that 
CaP-PILP is a fluid despite its very high viscosity. The strain-
dependent oscillatory rheology of CaP-PILP exhibited a broad 
linear viscoelastic region, indicating that this material has a 
wide processing range within the strain domain of 0.1%–100%. 
Taken together, the results indicate that CaP-PILP is a viscous, 
transparent, liquid-like precursor phase with a high density of 
uniform-sized ACP clusters.
The liquid-like CaP-PILP can be solidified after being 
injected into moulds kept at 37 °C for 7 d (Figure 1d). Con-
ventional transmission electron microscopy (TEM) showed that 
the amorphous phase transforms into nanorod/nanoplate-like 
structures with a length of ≈20 nm (Figure S2a, Supporting 
Information). SAED (Figure S2b, Supporting Information) 
and pXRD (Figure 1e) provided evidence for an amorphous-to-
crystal transition, showing an increase in the reflections corre-
sponding to both the (002) and (211) planes of HAP over time. 
The formation of HAP was further confirmed by the appear-
ance of phosphate v4 bending vibrations at 565 and 600 cm−1 
at the expense of the broad band at 560 cm−1 (Figure S2c, Sup-
porting Information).[40] The thermogravimetric and differential 
thermal analysis (TG/DTA) measurements (Figure 1f) revealed 
an endothermic peak between 20 and 200 °C and an exothermic 
peak between 200 and 400 °C, which are assigned to the loss 
of water and the decomposition of organics, respectively. The 
TG curves showed that the solidified material is composed of 
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69.4 wt% mineral, 19.3 wt% organics, and 11.3 wt% water. 
The solidification and crystallization of CaP-PILP is related to 
the conversion of the ≈1 nm clusters, which is similar to the 
0.7–1.0 nm sized “Posner’s clusters.”[39,41] Posner’s clusters act 
as the basic building blocks to generate larger ACP nanoparti-
cles by cluster-cluster complex aggregation.[5] By taking up the 
extra-OH groups and calcium ions into the voids within the 
ACP precursors, HAP can be further formed.[42,43] Generally, 
the solidification and crystallization of these clusters to HAP is 
fast and occurs within hours.[5] However, those processes are 
extended to days in our CaP-PILP due to the stabilization effect 
from PAA and PASP.
The CaP-PILP was then used for the remineralization of type I 
collagen fibrils. The native collagen fibrils (self-assembled 
from rat tail type I collagen) display periodic gap and overlap 
regions (Figure 2a). The TEM grids coated with the collagen 
fibrils were then floated at 37 °C oven the CaP-PILP as well 
as a suspension of commercial HAP nanocrystals. After 7 d of 
contact with the commercial HAP nanocrystals, the fibrils were 
barely mineralized, and HAP nanocrystals were observed only 
around the collagen fibrils (Figure 2b). In contrast, the CaP-
PILP-treated fibrils showed increased levels of mineralization 
with time (Figure 2c–e), while SAED confirmed that HAP is 
the final mineral product (insets in Figure 2c–e). The intrafi-
brillar mineralization of collagen was demonstrated using 3D 
super-resolution stochastic optical reconstruction microscopy 
(STORM) (Figure 2f–j). For this experiment, the collagen fibrils 
were labeled before mineralization with the red-emitting fluo-
rescent reagent cy3B. After 7 d, the mineralized collagen fibrils 
were stained with 10.0 × 10−6 m calcein to label the newly gener-
ated HAP nanocrystals. The results showed that crystals form 
within the collagen fibrils (Figure 2j), and the degree of miner-
alization in the collagen fibrils is approximately 95%.
To exclude possible endotoxin contamination, suspen-
sions of commercial ACP nanoparticles (ACP group, size of 
≈80 nm, Figure S3a, Supporting Information), HAP nano-
particles (HAP group, ≈150 × 30 × 1.5 nm, Figure S3b, Sup-
porting Information), or CaP-PILP were incubated with 
RAW264.7 cells and assessed for the secretion of the inflam-
matory cytokine IL-6, respectively, which is a sensitive readout 
for the presence of endotoxins.[44] The IL-6 release of CaP-PILP 
was similar to that of the ACP, HAP, and control groups after 
culturing for 1, 6, and 24 h, indicating that CaP-PILP did not 
promote the secretion of IL-6 compared with the ACP, HAP, 
and control groups (Figure S4, Supporting Information). To 
investigate the biocompatibility and osteoinductive capacity 
of CaP-PILP, bone marrow-derived mesenchymal stem cells 
(MSCs) were cultured with CaP-PILP using ACP group, HAP 
group, and osteogenic medium only (blank group) as controls. 
In terms of cell differentiation, the expression of alkaline phos-
phatase (ALP) in MSCs cultured with the ACP, HAP, and CaP-
PILP groups all increased after 7 d compared with that of the 
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Figure 1. Preparation, fluidity, and characterization of the CaP-PILP. a) Photograph of CaP-PILP, indicating that the material is viscous but still free 
flowing. b) Cross-section through the 3D reconstruction of a cryoET image of CaP-PILP, showing that the nanoclusters are homogeneously distributed 
and separated. Zoomed-in and close-to-focus cryoTEM images showing that the size of the clusters is ≈1 nm (inset 1), while the SAED pattern shows 
that the clusters are amorphous (inset 2). c) Rheological characterization of CaP-PILP, showing the frequency-dependent (at a strain of 1%, black 
lines) and strain-dependent (ω = 10 rad s−1, red lines) oscillatory shear rheology. d) Solidified CaP-PILP with different shapes. e) 3D pXRD patterns of 
the solidified CaP-PILP during solidification. f) TG (black line)/DTA (red line) curves of the solidified CaP-PILP. The weight loss at 200 °C is attributed 
to the loss of water, and the dominant weight loss occurs between 200 and 400 °C, corresponding to the decomposition of organics in the solidified 
CaP-PILP. W: water, O: organics, S: the solidified CaP-PILP. Scale bars: a,d) 2 cm, b) 10 nm, 5 nm (inset 1 in (b)).
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blank group (Figure S5a–d,m, Supporting Information). The 
ALP activity of the CaP-PILP group is similar to that of the 
HAP group, slightly higher than that of the ACP group, and 
≈2.4 times higher than that of the blank group, revealing 
that CaP-PILP can promote the differentiation of MSCs 
(Figure S5m, Supporting Information). Another biochemical 
marker of in vitro osteogenic differentiation, calcium deposi-
tion,[45] was also investigated for the MSCs after culturing with 
osteogenic medium for 14 d (Figure S5e–h,n, Supporting Infor-
mation). We observed that the calcium deposition increased for 
the ACP, HAP, and CaP-PILP groups compared with that of 
the blank group (Figure S5e–h, Supporting Information). The 
quantitative analysis showed that the optical density (OD) value 
of the CaP-PILP group was ≈2.0, 1.5, and 20.0 times that of the 
HAP, ACP, and blank groups, respectively (Figure S5n, Sup-
porting Information). However, without MSCs, calcium deposi-
tion of the four groups with osteogenic medium was relatively 
low, and the OD values of the blank, ACP, HAP, and CaP-PILP 
groups were 4.6 × 10−2, 5.1 × 10−2, 4.7 × 10−2, and 6.2 × 10−2, 
respectively (Figure S5i–l,o, Supporting Information). In gen-
eral, the results indicated that CaP-PILP provides a suitable 
physicochemical and biological microenvironment for the dif-
ferentiation of MSCs, which is essential for in vivo osteoporotic 
bone recovery.
The affinity of CaP-PILP for bone was studied by measuring 
the permeability of a rhodamine B-containing droplet of CaP-
PILP into osteoporotic bone, which simulates the in vivo infil-
tration of CaP-PILP to osteoporotic bone (Figure 3a–d). After 
placing the purple CaP-PILP droplet on the milky white osteo-
porotic bone for 30 s, the droplet extended on the surface of 
the osteoporotic bone (Figure 3b). After 2 h, the purple color 
was uniformly distributed throughout the osteoporotic bone, 
indicating excellent permeability (Figure 3c,d). After treatment 
with CaP-PILP for 1 d, ACP was observed surrounding and 
entering the collagen fibrils (Figure 3f), and remineralization 
of the collagen fibrils could be observed after 7 d, The SAED 
patterns confirmed that the mineral phase is HAP (Figure 3g). 
In contrast, without CaP-PILP treatment, demineralized col-
lagen fibrils were observed in the osteoporotic bone (Figure 3e). 
We then investigated the in vitro osteoporotic bone recovery 
ability of CaP-PILP by injecting a suspension of HAP particles 
or CaP-PILP into osteoporotic bones. After incubation at 37 °C 
for 2 weeks, the samples were analyzed by micro-computed 
tomography (micro-CT), with the native, untreated osteoporotic 
bone, and healthy bone used as comparisons (Figure 3h–k). 
The HAP group showed little bone recovery (Figure 3i) and 
was similar to osteoporotic bone (Figure 3h). In contrast, the 
CaP-PILP group showed a clear recovery of osteoporotic bone 
Adv. Sci. 2019, 6, 1900683
Figure 2. Mineralization process of collagen fibrils. a) TEM image and SAED pattern (inset) of the native collagen fibrils. b) Failed mineralization of 
collagen fibrils after exposure to HAP for 7 d at 37 °C. c–e) TEM images and SAED patterns (insets) of the mineralization process of collagen fibrils 
using the CaP-PILP at different time points at 37 °C: c) 3 d, d) 5 d, and e) 7 d. SAED patterns showing diffraction rings corresponding to the (002), 
(211), and (004) crystallographic planes of HAP (insets in (c–e)). f–h) The xy projections of STORM images of mineralized collagen fibrils. f) The 
collagen fibrils were labeled with cy3B, emitting red fluorescence, while g) HAP was labeled with calcein, emitting green fluorescence. i) 3D STORM 
image of the mineralized collagen fibrils shown in inset (h). j) Z-slice of STORM images of the mineralized collagen fibrils, indicating that the HAP is 
on/in the collagen fibrils. Scale bars: a,b,f–j) 200 nm and c–e) 600 nm.
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(Figure 3j), with a result that was comparable to healthy bone 
(Figure 3k). To quantify the amount of newly recovered bone, 
histomorphometry analysis was performed to obtain the bone 
volume/tissue volume ratio (BV/TV). The BV/TV values of 
the osteoporotic bone, HAP recovered bone, CaP-PILP recov-
ered bone, and healthy bone were 0.13, 0.19, 0.45, and 0.47, 
Adv. Sci. 2019, 6, 1900683
Figure 3. Affinity of CaP-PILP to osteoporotic bone and in vitro results of osteoporotic bone and recovered bone. a–d) Affinity of CaP-PILP to osteo-
porotic bone. a) Osteoporotic bone. b–d) The affinity of CaP-PILP was measured by placing drops of the purple CaP-PILP staining solution onto the 
osteoporotic bone at 37 °C for b) 30 s and c) 2 h. d) The section of the stained osteoporotic bone indicated that CaP-PILP was uniformly distributed 
throughout the osteoporotic bone after 2 h. e–g) TEM images and SAED patterns of e) osteoporotic bone (inset in (e)), f) CaP-PILP treated bone for 
1 d (inset in (f)), and g) 7 d (inset in (g)). h–k) Representative 3D micro-CT of h) osteoporotic bone, i) HAP recovered bone, j) CaP-PILP recovered 
bone, and k) healthy bone. l) The quantitative results of the 3D micro-CT analysis expressed as BV/TV. OB: osteoporotic bone. HAP: HAP-recovered 
bone. CaP-PILP: CaP-PILP recovered bone. Healthy: sham-operation bone. n = 3, **p < 0.01. m) SEM image of osteoporotic bone. n–p) Representative 
STEM image (n), SAED pattern (inset in (n)) and the corresponding element mapping (o–p) of osteoporotic bone. Calcium (o) and phosphate (p) 
atoms were labeled by blue and purple, respectively. q) SEM image of CaP-PILP recovered bone. r–t) Representative STEM image (r), SAED pattern 
(inset in (r)) and the corresponding element mapping (s–t) of CaP-PILP recovered bone. Calcium (s) and phosphate (t) atoms were labeled by red and 
green, respectively. Scale bars: a–d) 100 µm, e–g,r–t) 100 nm, h–k) 0.5 mm, m,q) 10 µm, n–p) 200 nm.
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respectively, indicating the excellent performance of CaP-PILP 
in recovering osteoporotic bone (Figure 3l). The scanning elec-
tron microscopy (SEM) images further supported the micro-CT 
results, showing the high porosity of the HAP (Figure S6a, Sup-
porting Information) and osteoporotic bone groups (Figure 3m) 
compared with that of the CaP-PILP (Figure 3q) and healthy 
groups (Figure S6b, Supporting Information). Scanning trans-
mission electron microscopy (STEM) showed that osteoporotic 
bone is deficient in calcium and phosphate (Figure 3n–p), and 
the SAED patterns confirmed that there is little mineral present 
(inset in Figure 3n). However, abundant calcium and phosphate 
atoms were in the CaP-PILP recovered bone (Figure 3r–t). The 
diffraction patterns of HAP for the CaP-PILP recovered bone, 
however, showed (002) diffraction arcs following the long axis 
of the collagen fibrils (inset in Figure 3r). These results demon-
strated that CaP-PILP can effectively recover osteoporotic bone 
in vitro.
Subsequently, the in vivo osteoporotic bone recovery capa-
bility of CaP-PILP was evaluated in ovariectomized osteoporotic 
mouse tibia using a percutaneous mini-invasive injection 
syringe at 4, 8, and 12 weeks (Figure 4a). To determine the loca-
tion of the injected CaP-PILP, in vivo imaging was performed 
on living osteoporotic mice to locate the fluorescence signals 
from calcein-stained CaP-PILP (Figure S7, Supporting Infor-
mation). After injecting the calcein-stained CaP-PILP droplet 
into the osteoporotic mouse tibia for 30 min, the green fluo-
rescence signal from CaP-PILP extended into the osteoporotic 
bone (Figure S7a, Supporting Information). After 2 h, the 
green color infiltrated throughout the tibia, indicating that 
CaP-PILP has been nicely distributed in the tissue (Figure S7b, 
Supporting Information). The bone loss results from oestrogen 
deficiency due to enhanced bone resorption and impaired oste-
oblast function.[46] In the experiments, the control group was 
subjected to a bilateral ovariectomy, which limited the secre-
tion of oestrogen, resulting in osteoporosis. The control group 
cannot heal naturally during the lifetime of the mice because 
the osteoporotic bone lacked mineral supply. Representative 2D 
and 3D micro-CT images of the osteoporotic bone, phosphate-
buffered saline (PBS), CaP-PILP, and healthy bone (sham-
operation) groups at postoperative weeks 0, 4, 8, and 12 are 
provided in Figure 4b–i and Figures S8–S10 in the Supporting 
Information. In the osteoporotic bone and PBS groups, hardly 
any new bone formation occurred over time (Figures S8–S10, 
Supporting Information). In contrast, after 4 weeks, new bone 
formation was significantly increased in the CaP-PILP group 
(Figure 4c,g). After 8 weeks, the healing status of the CaP-
PILP group (Figure 4d,h) was already comparable with that of 
the healthy bone group (Figures S8c,f, S9c,f, and S10c,f, Sup-
porting Information). No further growth of new bone tissue 
was detected at postoperative week 12 (Figure 4e,i), indicating 
that in the CaP-PILP group, the bone recovery reached its 
summit after 8 weeks. Haematoxylin and eosin (H&E) staining 
also demonstrated that the CaP-PILP group showed abundant 
newly formed bone tissue after 8 and 12 weeks (Figure 4l,m) 
and was nearly comparable with the healthy bone group 
(Figures S8i, S9i, and S10i, Supporting Information), while 
scare newly formed bone was detected in the osteoporotic bone 
and PBS groups (Figures S8g,h, S9g,h, and S10g,h, Supporting 
Information). The BV/TV, trabecular number (Tb.N) and tra-
becular separation (Tb.Sp) of the four groups were analyzed to 
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Figure 4. Schematic of the percutaneous mini-invasive injection and in vivo results of CaP-PILP-recovered bone after 0, 4, 8, and 12 weeks. a) Thirty 
30 µL of prepared CaP-PILP was percutaneously mini-invasively injected into the mouse osteoporotic tibia. b–m) Representative 2D, 3D micro-CT, and 
H&E staining of CaP-PILP-recovered bone at b,f,j) 0 weeks, c,g,k) 4 weeks, d,h,l) 8 weeks, and e,i,m) 12 weeks. NB (red arrows): new bone. BMC (blue 
arrows): bone marrow cells. Scale bars: b–e) 100 µm; f–i) 300 µm; and j–m) 200 µm.
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quantify the amounts of osteoporotic bone and newly formed 
bone (Figure 5a–c) and were shown to remain constant for the 
osteoporotic bone, PBS, and healthy bone groups after 4, 8, and 
12 weeks. The BV/TV and Tb.N of the CaP-PILP group, how-
ever, increased by factors of approximately 2.6 or 1.3, respec-
tively, after 8 weeks, while the Tb.Sp decreased. The values 
were all comparable with those of the healthy bone group, indi-
cating that CaP-PILP remarkably promotes new bone forma-
tion in osteoporotic regions. Similar to the in vitro experiments, 
elemental mapping and SAED revealed that the osteoporotic 
bone and PBS recovered bone showed a strongly reduced min-
eral content (Figure S11a,b, Supporting Information), while the 
CaP-PILP recovered bone showed the formation of HAP crys-
tals with their c-axis aligned along the collagen fibrils, similar to 
that in healthy bone (Figure S11c,d, Supporting Information). 
These results confirmed that treatment with CaP-PILP is a 
promising method for rapid osteoporotic bone recovery in vivo.
The mechanical properties of the osteoporotic bone and 
recovered bone were also tested (Figure 5d–e). The results 
showed that the hardness values of the osteoporotic bone, 
PBS recovered bone, CaP-PILP treated bone, and healthy bone 
were 116.5, 137.7, 371.8, and 280.5 MPa, respectively, while 
the Young’s moduli were 5.3, 5.2, 14.3, and 13.9 GPa, respec-
tively (Figure 5d). The recorded compressive stress–strain curve 
can be divided into three main regions: linear elastic, plateau, 
and densification. For these four groups, the stiffness of the 
materials was determined from the maximum value of the 
stress–strain slope in the linear elastic region.[47] The compres-
sive stress–strain measurements indicated that the stiffness 
values of the osteoporotic bone, PBS recovered bone, CaP-PILP 
recovered bone, and healthy bone were 23.4, 23.6, 50.2, and 
48.3 MPa, respectively (Figure 5e). These results demonstrate 
that our CaP-PILP can effectively enhance the mechanical per-
formance of osteoporotic bone and that the recovered zones dis-
played a similar (even higher) stiffness and hardness to those 
of healthy bone, which makes CaP-PILP an excellent candidate 
for osteoporotic bone recovery. The TG curves showed that the 
CaP-PILP recovered bone was composed of 68.3 wt% mineral, a 
value that was very similar to what was found for healthy bone 
(66.8 wt% mineral), while the mineral ratio in the osteoporotic 
bone and PBS groups was only ≈50.0 wt% (Figure 5f).
In this work, the bone-inductive CaP-PILP is synthesized and 
used for osteoporotic bone recovery as an alternative to tradi-
tional osteoporotic bone treatment methods. The resulting CaP-
PILP can penetrate into osteoporotic bone tissue to induce the 
intrafibrillar mineralization of collagen fibrils with HAP, a key 
aspect in effectively recovering osteoporotic bone tissue. The 
recovered bone displays good mechanical performance and is 
comparable with healthy bone. The fluidity of CaP-PILP allows 
for the minimally-invasive injection recovery of osteoporotic 
bone, without the need for surgical incision in clinical appli-
cations. More generally and fundamentally, our results provide 
the first proof that the structure and mechanical performance 
of osteoporotic bone can be recovered to their healthy state by 
treatment with CaP-PILP.
Experimental Section
Preparation of CaP-PILP: In a typical procedure, 2.0 mL of a 
0.1 m CaCl2 solution was first mixed with 0.2 mL of a 0.3 g mL−1 PASP 
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Figure 5. Quantitative results of micro-CT analysis, mechanical testing, and TG analysis of osteoporotic bone, recovered bone, and healthy bone. Quan-
titative results of micro-CT analysis expressed as a) BV/TV, b) Tb.N, and c) Tb.Sp. d) Young’s modulus and hardness, e) stiffness, and f) TG analysis 
of the four groups. The results showed that the inorganic ratio of CaP-PILP-recovered bone is similar to that of healthy bone, while the inorganic ratio 
of PBS-recovered bone is similar to that of osteoporotic bone. OB: osteoporotic bone, PBS: PBS-recovered bone, CaP-PILP: CaP-PILP-recovered bone, 
Healthy: sham-operation bone. a–c) n = 5, *p < 0.05, d) n = 6, ***p < 0.001, e) n = 3, *p < 0.05.
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(Mw = 9–11 kDa) solution to obtain solution A, while 2.0 mL of a 
0.1 m Na2HPO4 solution was mixed with 0.4 mL of a solution containing 
0.3 g mL−1 PAA (Mw = 450 kDa) to obtain solution B. Then, 2.4 mL of 
solution B was slowly injected into 2.2 mL of solution A with vigorous 
stirring, and the pH value was adjusted to 7.4 with NaOH solution.
CryoTEM of CaP-PILP: CryoTEM Au grids (R2/2 Quantifoil Jena Grids) 
were treated by glow discharge for 40 s to increase their hydrophilicity. 
Three microliter of CaP-PILP was applied on the grid, and then the grid 
was blotted for 3 s, relaxed for 60 s to allow the formation of a thin 
liquid layer, and vitrified by plunging into liquid ethane at liquid nitrogen 
temperature. CryoTEM imaging was performed under an ≈1 µm defocus 
on an FEI-Titan TEM equipped with a field emission gun operating at 
300 kV. The images were recorded using a 2k  ×  2k Gatan CCD camera 
equipped with a postcolumn Gatan energy filter (GIF), with an electron 
dose of 16 e Å−2 per image. A cryogenic tomography tilt series was 
recorded by tilting the holder from −65 to +65 degrees using the Saxton 
tilt increment scheme (87 images were taken in total).[48] The images 
were recorded under an ≈3 µm defocus, with an electron dose of 
2 e Å−2 per image.
Rheological Test: The rheology experiments were performed on an 
Anton Paar rheometer at 25 °C. CaP-PILP was prepared and gently 
placed in the middle of a 15 mm diameter parallel plate with a proper 
gap. Dynamic oscillatory frequency sweep measurements were 
conducted at a 1% strain amplitude. To prevent evaporation, a lid was 
prepared on the top.
Pro-Inflammatory Cytokines (IL-6): To test the inflammatory response 
of CaP-PILP, RAW264.7 cells were cultured with CaP-PILP, a suspension 
of ACP particles, a suspension of HAP particles, and medium only at 
37 °C for 1, 6, and 24 h, respectively. The concentration of the cytokines 
IL-6 was measured by ELISA using antibodies obtained from Biolegend 
according to the manufacturer’s instructions (R&D Systems).
Osteogenic Differentiation: Four types of media were prepared and 
coated onto 24-well Petri dishes: 50 µg CaP-PILP, commercial ACP 
particles, HAP particles, and a blank. All the groups were sterilized 
overnight under ultraviolet germicidal lamps. The osteogenic medium 
was composed of 10−8 m dexamethasone, 50 µg mL−1 ascorbic acid, 
10 × 10−3 m β-glycerol phosphate, 10% fetal bovine serum (FBS), and 
high-glucose Dulbecco’s modified Eagle’s medium (DMEM). Then, 
MSCs were seeded in the above 24-well Petri dishes at a density of 
1 × 104 cells/well. The media changed every other day, and the MSCs 
in the four groups were incubated at 37 °C in a humidified atmosphere 
containing 5% CO2. After the MSCs were cultured for 1 week in 
osteogenic medium, the ALP activity was examined using a commercial 
detection kit (Beyotime, C3206). The cell nuclei were stained with 
4′, 6-diamidino-2-phenylindole (DAPI) to count the total cell number 
and calculate the ALP staining positive rate of the MSCs. The calcium 
deposits formed were also stained by the MSCs with Alizarin Red S 
(ARS) after culturing in osteogenic medium for 14 d. To further quantify 
the results of the ARS staining, the stained nodules were solubilized 
with 5% sodium dodecyl sulfate (SDS) in 0.5 m HCl for 30 min at room 
temperature. Finally, the OD value of the solution was measured at a 
wavelength of 405 nm.
Self-Assembly of Collagen Fibrils on the TEM Grids and Laser Confocal 
Culture Dish (LCCD) and Collagen Mineralization: A 3 mg mL−1 stock 
solution of type I collagen was purchased from Gibco-Invitrogen. The 
assembly solutions contained 50 × 10−3 m glycine and 200 × 10−3 m KCl, and 
the pH was adjusted to 9 using NaOH solution. An 8.33 µL volume of the 
collagen stock solution was added dropwise into 0.5 mL assembly solution 
and incubated for 20 min at 37 °C. 3 µL of the incubated collagen solution 
was placed on a nickel TEM grid for 12 h and then rinsed with deionized 
water. For the LCCD samples, 100 µL collagen solution (50 µg mL−1) 
was placed dropwise over an aminopropyltriethoxysilane (APTES)-modified 
LCCD glass substrate, incubated at a constant temperature of 37 °C for 
12 h and washed with deionized water. Then, the collagen fibrils were 
further cross-linked with 0.05% glutaraldehyde for 4 h. TEM grids loaded 
with collagen fibrils were floated on the CaP-PILP for mineralization. The 
mineralization degree of the collagen fibrils was quantified using ImageJ 
based on the method used in the previous work.[49] Briefly, the pixel 
intensities of the mineralized collagen fibrils and nonmineralized collagen 
fibrils in the TEM images was different. The nonmineralized region 
contains light atoms (C, H, and N), while the mineralized portion contains 
extra heavier atoms (Ca and P). As a result, the mineralized region has 
a lower pixel intensity comparing with the nonmineralized region, and 
the areas of the mineralized region (S1) and nonmineralized region (S2) 
can be obtained by segmenting the image based on pixel intensities. 
The mineralization degree (m.d.) is calculated by (six TEM images were 
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3D STORM Imaging: The collagen fibrils were labeled with a 
fluorescent reagent by immunofluorescence staining. CaP-PILP was 
incubated with blocking buffer (Beyotime, China, Product Code: P0023B) 
for 1 h at 37 °C. After washing three times, the samples were incubated 
with Cy3B-conjugated secondary antibodies for 2 h. After that, 1 mL 
of CaP-PILP was placed dropwise onto the LCCD, which was loaded 
with immunofluorescence-stained fibrils. The material was incubated 
at 37 °C for 6 h and rinsed with deionized water three times. Then, 
the mineralized collagen fibrils were labeled with 10 × 10−6 m calcein 
for 20 min and rinsed with deionized water three times. All STORM 
imaging experiments were performed on a Nikon Ti-E inverted optical 
microscope, the movies and images were analyzed by Nikon NIS-
Elements AR software.
In Vitro Recovery of Osteoporotic Bone: In vitro experiments were used 
to detect the mineralization properties of CaP-PILP for collagen fibrils 
in osteoporotic bones without cells or vessels. Female Sprague Dawley 
osteoporotic bones and healthy bones were kindly provided by the Sir 
Run Run Shaw Hospital Affiliated with the Medical College of Zhejiang 
University, and the use of animal tissues for the in vitro study was 
approved by the guidelines on the care and use of animals for scientific 
purposes issued by the National Institutes of Health (NIH) and Zhejiang 
University. First, models with ovariectomized-induced 8-week-old female 
Sprague Dawley (body weight, 290–330 g) osteoporotic rats were created. 
Then the healthy rats and osteoporotic rats were scarified to obtain the 
femurs. After that, the healthy femurs and osteoporotic femurs were cut 
into slices and dried in an oven at 37 °C for seven days prior to use. CaP-
PILP was synthesized by the above method, and the HAP was made by 
suspending commercial HAP particles into a PBS solution. CaP-PILP or 
HAP particles were injected into the osteoporotic bones, and then the 
bones were placed in a water bath at 37 °C for 14 d. After that, the bones 
were dried at room temperature before further experiments.
In Vivo Recovery of Osteoporotic Bone: All animal experiments were 
performed at the Sir Run Run Shaw Hospital Affiliated with the Medical 
College of Zhejiang University. All handling and care of the animals were 
carried out according to the guidelines on the care and use of animals 
for scientific purposes issued by the NIH and Zhejiang University. First, 
models with ovariectomized-induced osteoporotic bone were created. 
All mice in this model were deprived of any food for 6 h before being 
anaesthetized. Each mouse in this model was given a general anesthetic 
of 50 mg kg−1 pentobarbital sodium by intraperitoneal injection and 
then fixed in the prone position. The psoas muscles were cut along 
the linea scapularis subcostals at the two sides to expose the ovaries 
and uterine horns under the kidneys, and then ligature was conducted. 
Subsequently, the uterine horns were cut, the ovaries were completely 
extracted, the incision was sewn closed layer by layer, and the model 
creation surgery was complete. The removed tissue was examined 
to ensure the completeness of the surgery, and the ovaries were 
confirmed by histological determination. In the sham-operation mice, 
the incisions were made without resection. Briefly, 65 healthy 8-week-old 
female C57BL/6 mice (body weight, 20–25 g) were used in this study. 
50 mice were randomly selected for the ovariectomized groups, and 
the rest (15 mice) were used as the healthy group (sham operation). 
The ovariectomized mice were randomly divided into three groups: 
osteoporotic bone (no intervention), PBS, and CaP-PILP (n = 10) groups. 
The different administrations began at the 6th week after oophorectomy. 
All the materials were filtered through 0.22 µm Millipore films prior to 
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use. Then, 30 µL of the prepared CaP-PILP or PBS was percutaneously 
mini-invasively injected into the osteoporotic tibia after anaesthetization 
(30 µL is the maximum injection). After that, all the mice remained 
in good health and did not show any wound symptoms throughout 
four, eight, and twelve weeks of experiments. All mice were sacrificed 
after 0, 4, 8, and 12 weeks according to the animal ethics regulations. 
The uteri were isolated and weighed to confirm the effects of the 
ovariectomy, and the tibia specimens were harvested and fixed in 4% 
(w/v) paraformaldehyde for further observation.
Micro-CT Scanning: A high-resolution micro-CT (Skyscan 1072; 
Skyscan, Aartselaar, Belgium) scanner was used to analyze the fixed tibia, 
operating at a voltage of 80 kV and a current of 80 µA. The micro-CT 
scanner’s auxiliary software was used to make a 3D reconstruction from 
the sequential scans. The quantitative results of the micro-CT analysis 
were measured using the CTAn program.
Histological Procedure: The specimens were fixed with 4% 
paraformaldehyde and decalcified in 10% ethylenediaminetetraacetic 
acid for 4 weeks at pH 7.1 and 4 °C. The samples were then embedded in 
paraffin, and serial sections with a 5 µm thickness were prepared. Three 
randomly selected sections from each implant were stained with H&E, 
and the sections were observed by optical microscopy (Nanozoomer, 
2.0RS, Hamamatsu, Japan).
Evaluation of Mechanical Properties: After the mice were sacrificed, 
the tibias were removed intact from the surrounding bone. The Young’s 
modulus and hardness of the CaP-PILP-recovered bone and PBS-
recovered bone were compared to the properties of the osteoporotic 
bone and healthy bone. A nanoindentation test using the Berkovich tip 
was used to analyze the modulus and hardness of each section (G200, 
Agilent Technologies, CA, USA). The data were recorded and managed 
by Testworks 4 software (MTS System Corporation, Eden Prairie, MN, 
USA), which calculated the modulus and hardness. The ultimate 
compressive stress–strain was determined by using a computer-
controlled test machine (Z2.5, Zwick/Roell, Ulm, Germany). Each tibia 
was cut into a 0.5 cm portion to measure the mechanical properties. 
The samples were compressed to failure at a rate of 1 mm min−1. Three 
replicates for each group were tested. The compressive stress–strain 
curve can be divided into three main regions: linear elastic, plateau, and 
densification. To calculate the stiffness, the initial nonlinear behavior 
was disregarded in the subsequent analysis of the data. The stiffness 
of each group was determined from the maximum slope of the stress-
strain curve in the linear elastic region.
Statistical Analysis: The testing data were described as the means 
and standard deviations for at least three samples. The mean value 
was statistically compared among the groups using a one-sample 
t-test. Probability values less than 0.05 were considered significant. A 
commercially available software program (Origin 8.5, Electronic Arts 
Inc., USA) was used for the statistical analysis.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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